Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.9500
+0.0200 (2.15%)
At close: Aug 13, 2025, 4:00 PM
0.9500
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $9.63 million as of August 14, 2025. Its market cap has increased by 53.86% in one year.
Market Cap
9.63M
Enterprise Value
7.39M
1-Year Change
53.86%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $9.63M, a decrease of -72.70%. That is a compound annual growth rate of -28.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 9.63M | 14.03% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |